Allgens Medical

Allgens Medical Technology CO.,LTD. (formerly Allgens Medical) was established in 2004 and is a national high-tech enterprise focusing on the technological research and development, advanced manufacturing, and market promotion of high-end regenerative medicine materials and implantable medical devices. Under the care and guidance of the Party and leaders at all levels, with the support and assistance from the Zhongguancun High-End Medical Device Park, and through the relentless efforts of all employees, Allgens has grown over 15 years to become a leading company in China’s regenerative medicine material and medical device field. Its product technology, clinical recognition, brand influence, and annual sales revenue are all at the forefront of the industry. The "mineralized collagen biomimetic artificial bone technology" has been a global challenge. After continuous efforts, Allgens successfully developed the world's first mineralized collagen biomimetic bone material in 2011, whose composition and structure are highly similar to natural human bone tissue. It completed the specific work of technical industrialization and clinical transformation while establishing a fully independent intellectual property rights platform for in vitro biomimetic mineralization of bone collagen. This achievement places China in an internationally leading position in the high-end medical device field of biomimetic artificial bone repair materials. The mineralized collagen biomimetic bone series products have now obtained three Class III medical device product registrations from China's CFDA and one U.S. 510(k) market entry permit. The material composition and microstructure of the mineralized collagen biomimetic artificial bone closely resemble those of human bone tissue and can be widely used for bone defect repairs in orthopedics, dentistry, neurosurgery, and plastic surgery. These products have been clinically applied in over a million cases with remarkable bone defect repair results, bringing health and happiness to numerous patients and their families.